Patients with gastric neoplasia (gastric adenoma, early gastric cancer)
Conditions
Interventions
Sponsors
Department of Gastroenterology, Juntendo University School of Medicine, Tokyo, Japan
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Patients who undergo ESD for early gastric cancer or gastric adenoma. 2.Patients who give a written informed consent.
Exclusion criteria
Exclusion criteria: 1.Pregnancy or lactation. 2.Past history of allergy for the drugs used in this therapy. 3.Patients on some form of antithrombotic therapy or NSAIDs, adrenocorticosteroid. 4.Severe liver dysfunction, Severe renal dysfunction, Severe heart dysfunction. 5.Patients who are disqualified for the study by physicians.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Gastric ulcer stage and ulcer size reduction rate after 4 weeks treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| Rate of post-operative bleeding | — |
Countries
Japan
Contacts
Public ContactHiroya Ueyama
Juntendo University School of Medicine Department of Gastroenterology
Outcome results
None listed